Literature DB >> 28526938

Reducing Liver Cancer Risk in African-Born Immigrants Through Culturally Targeted Hepatitis B Group Education Programs.

Kemi Bolutayo1, Alexandre Ly van Manh2,3, Noah Cohen2, Daouda Ndiaye4, Lina Jandorf2, Ponni V Perumalswami2,3.   

Abstract

Of 900 West African-born immigrants living in New York City who were tested for hepatitis B virus (HBV), over 9% were found to have the infection (Shankar H et al. Clin Infectious Dis 62(S4):S289-s297, 2016). Community targeted group education programs (EP) have been shown to improve immigrant population's health (Bailey E et al. J Natl Med Assoc 92(3):136-42, 2000). Our aim is to enhance HBV screening in at-risk West African immigrants through the development of a group EP as a first critical step to reducing liver cancer risk. The framework for an HBV group EP was created based on our prior work to identify barriers and facilitators for HBV screening in this community (Sriphanlop, P et al. Am J Health Behav 5(10):745-754, 2014). The framework was then refined with input from community "gatekeepers" or leaders (n = 57) through four focus groups. After refining the group EP, we then pilot tested the EP with 154 participants from eight different West African communities with a pre-/post-test HBV knowledge survey assessment to determine the impact of the group EP. Results from the pre-/post-test survey assessment demonstrated a significant increase in HBV knowledge after the EP (70% pre-test vs. 88% post-test, p value <.01). Through a community-based participatory approach, a group EP could be effective in increasing knowledge about HBV infection and HBV screening as a first step to reducing liver cancer risk.

Entities:  

Keywords:  Cancer screening; Group education; Hepatitis B; Liver cancer; West African-born immigrants

Mesh:

Year:  2018        PMID: 28526938     DOI: 10.1007/s13187-017-1231-6

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  14 in total

1.  Health status, health insurance, and health care utilization patterns of immigrant Black men.

Authors:  Jacqueline W Lucas; Daheia J Barr-Anderson; Raynard S Kington
Journal:  Am J Public Health       Date:  2003-10       Impact factor: 9.308

2.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.

Authors:  J J Ott; G A Stevens; J Groeger; S T Wiersma
Journal:  Vaccine       Date:  2012-01-24       Impact factor: 3.641

3.  Physical and mental health characteristics of U.S.- and foreign-born adults: United States, 1998-2003.

Authors:  Achintya N Dey; Jacqueline Wilson Lucas
Journal:  Adv Data       Date:  2006-03-01

4.  Factors related to hepatitis B screening among Africans in New York City.

Authors:  Pathu Sriphanlop; Lina Jandorf; Clement Kairouz; Linda Thelemaque; Hari Shankar; Ponni Perumalswami
Journal:  Am J Health Behav       Date:  2014-09

5.  Provider, Patient, and Practice Factors Shape Hepatitis B Prevention and Management by Primary Care Providers.

Authors:  Nizar A Mukhtar; Priya Kathpalia; Joan F Hilton; Gene Lau; Albert Yu; Kevin Grumbach; Tung T Nguyen; Daniel Chan; Mandana Khalili
Journal:  J Clin Gastroenterol       Date:  2017-08       Impact factor: 3.062

6.  A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants.

Authors:  Hari Shankar; Demetri Blanas; Kian Bichoupan; Daouda Ndiaye; Ellie Carmody; Valerie Martel-Laferriere; Joan Culpepper-Morgan; Dougles T Dieterich; Andrea D Branch; Mulusew Bekele; Kim Nichols; Ponni V Perumalswami
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

7.  Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities.

Authors:  Ponni V Perumalswami; Stephanie H Factor; Luciano Kapelusznik; Scott L Friedman; Calvin Q Pan; Charissa Chang; Frances Di Clemente; Douglas T Dieterich
Journal:  J Hepatol       Date:  2013-01-15       Impact factor: 25.083

8.  Reducing liver cancer disparities: a community-based hepatitis-B prevention program for Asian-American communities.

Authors:  Chiehwen Ed Hsu; Louis Chih-Hung Liu; Hee-Soon Juon; Yu-Wen Chiu; Julie Bawa; Ulder Tillman; Mark Li; Jerry Miller; MinQi Wang
Journal:  J Natl Med Assoc       Date:  2007-08       Impact factor: 1.798

9.  Public health model for prevention of liver cancer among Asian Americans.

Authors:  Hee-Soon Juon; Carol Strong; Thomas H Oh; Theresa Castillo; Grace Tsai; Leslie D Hsu Oh
Journal:  J Community Health       Date:  2008-08

Review 10.  The Health Belief Model: a decade later.

Authors:  N K Janz; M H Becker
Journal:  Health Educ Q       Date:  1984
View more
  4 in total

1.  Effectiveness of Interventions for Hepatitis B and C: A Systematic Review of Vaccination, Screening, Health Promotion and Linkage to Care Within Higher Income Countries.

Authors:  Elizabeth Ortiz; Brighid Scanlon; Amy Mullens; Jo Durham
Journal:  J Community Health       Date:  2020-02

2.  Acceptability and Feasibility of Home-Based Hepatitis B Screening Among Haitian Immigrants.

Authors:  Patricia D Jones; Kristin Gmunder; Saradjine Batrony; Paul Martin; Erin Kobetz; Olveen Carrasquillo
Journal:  J Immigr Minor Health       Date:  2021-03-09

Review 3.  Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.

Authors:  Naoto Fujiwara; Scott L Friedman; Nicolas Goossens; Yujin Hoshida
Journal:  J Hepatol       Date:  2017-10-06       Impact factor: 30.083

4.  Knowledge, Attitudes, and Behaviors of Viral Hepatitis Among Recent African Immigrants in the United States: A Community Based Participatory Research Qualitative Study.

Authors:  Essa A Mohamed; Nasra H Giama; Hassan M Shaleh; Linda Kerandi; Abdul M Oseini; Hager Ahmed Mohammed; Henry Kerandi; Loretta K Allotey; Ibrahim A Waaeys; Hamdi A Ali; Hawa M Ali; Safra A Mohamed; Ju Dong Yang; Wudneh O Gaga; Lily L Tamire; Awol Windissa; Christi A Patten; Joyce E Balls-Berry; Lewis R Roberts
Journal:  Front Public Health       Date:  2020-03-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.